31 May Michael Davies appointed as new CEO
Michael Davies appointed as new CEO to turbocharge growth as healthcare sector rapidly moves towards digitisation
Global Health Limited (ASX: GLH) (“Global Health” or “Company”) is pleased to announce the appointment of Mr Michael Davies as Chief Executive Officer, to lead the Company through the next chapter in its 30-year history of providing software solutions to the Australian healthcare market.
Mr Davies joins Global Health with an extensive background leading technology adoption, driving sales and go-to-market strategies in the public and private sectors. He has over 20 years of experience across leading organisations including Telstra, Optus and most recently as Head of Revenue at Macquarie Telecom.
Mr Davies will join Global Health as CEO on 1 July 2021. His appointment comes as Global Health is poised for growth following significant investment in its SaaS products (MasterCare+, HotHealth, ReferralNet and Lifecard) over the past two years. His sales experience and leadership will be vital as the Company focuses on revenue growth, delivering exceptional customer engagement and customer success, and raising its profile with enterprise buyers across the healthcare sector.
Current Managing Director and CEO, Mathew Cherian, who founded the Company, will remain with Global Health in the new role of Executive Director. In his new role, Mr Cherian will focus on ensuring a smooth transition for Mr Davies, and leading Global Health’s strategic focus and expansion into new markets. Both Mr Davies and Mr Cherian will report to the Board. Mr Davies, as CEO will have full accountability for the performance and growth of the existing business, while Mr Cherian will focus on expansion into new markets, including the Asia-Pacific Region and, potentially mergers and acquisitions.
This transition is the culmination of the Board’s plan for CEO succession, which has been in train for two years. Chairman Steven Pynt said:
“This is an exciting new phase in the growth of the Company. The Board has been working on CEO succession for two years, but our plans were delayed by the COVID-19 pandemic. We are delighted to secure a CEO of Michael’s calibre and experience to lead the Company through its next growth and expansion phase. At the same time, his appointment will free up Mathew, the founder and major shareholder, to pursue other opportunities in Australia and internationally. The Board is very appreciative of the superlative job that Mathew has done to date in building Global Health, and we look forward to his ongoing involvement in a new capacity.”
Mr Michael Davies is equally excited about joining the Company for the next phase of its growth.
“I am both thrilled and excited to have the opportunity to lead Global Health, a Company that is challenging the status quo and making a difference for the patient journey. Modern patient care requires patient information and communication to happen seamlessly between many different care givers and specialists. I am excited to be able to lead a Company focused on achieving this, and creating a better patient journey and improved efficiency for providers.” Mr Davies said.
“By making the patient the centre of our mission, Global Health has developed software solutions that allow quality outcomes as patients move between different care providers. The medical and aged care sectors face real challenges with complex compliance needs and increasing pressure on costs whilst delivering exceptional patient outcomes.”
“I have been impressed by the way Global Health addresses patient outcomes with a focus on reducing cost and improving compliance for care providers. By providing a holistic solution, with the patient journey at the core, Global Health allows care providers to efficiently deliver services and patients and guardians to engage in their own medical journey.”
Outgoing CEO, Mr Mathew Cherian, sees Mr Davies as a critical part of accelerating the uptake of the Company’s solutions in the Australian healthcare industry, especially in Mental and Community Health settings where there are immediate benefits of using Global Health’s software.
“I am delighted Michael has chosen to join Global Health at this pivotal time for the Company and look forward to supporting him as he leads the Company through the next exciting phase of our growth.” Mr Cherian said.
Mr Davies will join Global Health’s leadership team, reporting to the Board, which consists of Steven Pynt, Mathew Cherian, Grant Smith and Robert Knowles.